Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma.

Stéphane Champiat,Nathalie Cassoux,Hélène Salaün,Ana Ines Lalanne,Raymond Barnhill,Olivier Lantz,Benjamin Besse,Francesca Lucibello,Manuel Rodrigues,Aurélien Marabelle,Nolwenn Metzger,Mathilde Saint-Ghislain,Marc-Henri Stern,Jean-Yves Scoazec,Sophie Gardrat,Etienne Rouleau,Leanne De Koning,Thomas Ryckewaert

doi:10.1200/po.22.00363

Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma.

Stéphane Champiat, Nathalie Cassoux + Show 16 more

https://doi.org/10.1200/po.22.00363

Copy DOI

Export

Save

Cite

Journal: JCO precision oncology

Publication Date: May 1, 2023

Affiliation: University of Paris-Saclay, Inserm, Université Paris Sciences et Lettres, Institute Curie, Institut Gustave Roussy, Institut Polytechnique de Paris, Centre Oscar Lambret

#Gustave Roussy #Metastatic Uveal Melanoma #Exceptional Response #Conflict Of Interest Policy #ASCO's Conflict #Open Payments #Foundation Grant #Conflict Of Policy #Public Database #Full Figures

Abstract
Full-Text
Similar Papers

Abstract

Listen

Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma.

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: JCO precision oncology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma.